LOSS PER COMMON SHARE - Antidilutive (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Shares subject to warrants outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to (in shares)	0	17,669	0	17,669
Shares subject to unvested or deferred performance and restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to (in shares)	3,086,823	2,310,588	3,086,823	2,310,588
Shares subject to stock options outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to (in shares)	409,017	577,961	409,017	577,961